Literature DB >> 26818244

Feeling Is Believing: Evaluative Conditioning and the Ethics of Pharmaceutical Advertising.

Paul Biegler1, Patrick Vargas2.   

Abstract

A central goal in regulating direct-to-consumer advertising of prescription pharmaceuticals (DTCA) is to ensure that explicit drug claims are truthful. Yet imagery can also alter viewer attitudes, and the degree to which this occurs in DTCA is uncertain. Addressing this data gap, we provide evidence that positive feelings produced by images can promote favourable beliefs about pharmaceuticals. We had participants view a fictitious anti-influenza drug paired with unrelated images that elicited either positive, neutral or negative feelings. Participants who viewed positive images rated the influenza drug as significantly more effective, safe, and beneficial than did participants who viewed negative images. This effect, known as evaluative conditioning, is well described in experimental social psychology but has not previously been shown with pharmaceuticals. We discuss how evaluative conditioning in DTCA may compromise viewer autonomy, and canvass possible regulatory responses.

Entities:  

Keywords:  Autonomy; Behavioural research; Drugs and drug industry; Health promotion; Informed consent

Mesh:

Substances:

Year:  2016        PMID: 26818244     DOI: 10.1007/s11673-016-9702-8

Source DB:  PubMed          Journal:  J Bioeth Inq        ISSN: 1176-7529            Impact factor:   1.352


  18 in total

1.  Evaluative conditioning in humans: a meta-analysis.

Authors:  Wilhelm Hofmann; Jan De Houwer; Marco Perugini; Frank Baeyens; Geert Crombez
Journal:  Psychol Bull       Date:  2010-05       Impact factor: 17.737

2.  Direct-to-consumer drug advertisements on network television: an exploration of quantity, frequency, and placement.

Authors:  Erica D Brownfield; Jay M Bernhardt; Jennifer L Phan; Mark V Williams; Ruth M Parker
Journal:  J Health Commun       Date:  2004 Nov-Dec

3.  Direct-to-consumer advertising: a haphazard approach to health promotion.

Authors:  Matthew F Hollon
Journal:  JAMA       Date:  2005-04-27       Impact factor: 56.272

4.  Direct-to-consumer advertising: should there be a free market in healthcare information?

Authors:  Andreas Hasman; Søren Holm
Journal:  Camb Q Healthc Ethics       Date:  2006       Impact factor: 1.284

5.  Should Canada allow direct-to-consumer advertising of prescription drugs?: no.

Authors:  Barbara Mintzes
Journal:  Can Fam Physician       Date:  2009-02       Impact factor: 3.275

Review 6.  Advertising of prescription-only medicines to the public: does evidence of benefit counterbalance harm?

Authors:  Barbara Mintzes
Journal:  Annu Rev Public Health       Date:  2012-04       Impact factor: 21.981

7.  Ban the sunset? Nonpropositional content and regulation of pharmaceutical advertising.

Authors:  Paul Biegler; Patrick Vargas
Journal:  Am J Bioeth       Date:  2013       Impact factor: 11.229

8.  Patients' memories of painful medical treatments: real-time and retrospective evaluations of two minimally invasive procedures.

Authors:  Donald A Redelmeier; Daniel Kahneman
Journal:  Pain       Date:  1996-07       Impact factor: 6.961

9.  Using a drug facts box to communicate drug benefits and harms: two randomized trials.

Authors:  Lisa M Schwartz; Steven Woloshin; H Gilbert Welch
Journal:  Ann Intern Med       Date:  2009-02-16       Impact factor: 25.391

10.  What are the public health effects of direct-to-consumer drug advertising?

Authors:  Elizabeth A Almasi; Randall S Stafford; Richard L Kravitz; Peter R Mansfield
Journal:  PLoS Med       Date:  2006-03-28       Impact factor: 11.069

View more
  1 in total

1.  Medicine, market and communication: ethical considerations in regard to persuasive communication in direct-to-consumer genetic testing services.

Authors:  Manuel Schaper; Silke Schicktanz
Journal:  BMC Med Ethics       Date:  2018-06-05       Impact factor: 2.652

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.